Cargando…

Distinguishing Health Benefits of Eicosapentaenoic and Docosahexaenoic Acids

Long chain omega-3 polyunsaturated fatty acids (LC n-3 PUFAs) are recommended for management of patients with wide-ranging chronic diseases, including coronary heart disease, rheumatoid arthritis, dementia, and depression. Increased consumption of eicosapentaenoic acid (EPA) and docosahexaenoic acid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russell, Fraser D., Bürgin-Maunder, Corinna S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509534/ https://www.ncbi.nlm.nih.gov/pubmed/23203276 http://dx.doi.org/10.3390/md10112535

Ejemplares similares

Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) in Muscle Damage and Function
por: Ochi, Eisuke, et al.
Publicado: (2018)

Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other?
por: Pal, Anandita, et al.
Publicado: (2020)

Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells
por: Bate, Clive, et al.
Publicado: (2008)

The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review
por: Innes, Jacqueline K., et al.
Publicado: (2018)

Omega-3 Fatty Acids Modulate Weibel-Palade Body Degranulation and Actin Cytoskeleton Rearrangement in PMA-Stimulated Human Umbilical Vein Endothelial Cells
por: Bürgin-Maunder, Corinna S., et al.
Publicado: (2013)

The Role of Endogenous Eicosapentaenoic Acid and Docosahexaenoic Acid-Derived Resolvins in Systemic Sclerosis
por: Avanoǧlu Güler, Aslıhan, et al.
Publicado: (2020)

Eicosapentaenoic acid and docosahexaenoic acid reduce interleukin-1β-mediated cartilage degradation
por: Wann, Angus KT, et al.
Publicado: (2010)

Docosahexaenoic acid, but not eicosapentaenoic acid, improves septic shock-induced arterial dysfunction in rats
por: Boivin, Alexandra, et al.
Publicado: (2017)

Determination of the Relative Efficacy of Eicosapentaenoic Acid and Docosahexaenoic Acid for Anti-Cancer Effects in Human Breast Cancer Models
por: VanderSluis, Laura, et al.
Publicado: (2017)

Effect of eicosapentaenoic and docosahexaenoic acid on resting and exercise-induced inflammation and oxidative stress
por: Bloomer, Richard, et al.
Publicado: (2009)

Effects of Dietary α-Linolenic Acid Treatment and the Efficiency of Its Conversion to Eicosapentaenoic and Docosahexaenoic Acids in Obesity and Related Diseases
por: Takic, Marija, et al.
Publicado: (2022)

Moderate Dietary Supplementation with Omega-3 Fatty Acids Does Not Impact Plasma Von Willebrand Factor Profile in Mildly Hypertensive Subjects
por: Bürgin-Maunder, Corinna S., et al.
Publicado: (2015)

Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Chylomicron and VLDL Synthesis and Secretion in Caco-2 Cells
por: Wang, Yue, et al.
Publicado: (2014)

Eicosapentaenoic acid but not docosahexaenoic acid restores skeletal muscle mitochondrial oxidative capacity in old mice
por: Johnson, Matthew L, et al.
Publicado: (2015)

Bioconversion From Docosahexaenoic Acid to Eicosapentaenoic Acid in the Marine Bacterium Shewanella livingstonensis Ac10
por: Ogawa, Takuya, et al.
Publicado: (2020)

Differential and shared effects of eicosapentaenoic acid and docosahexaenoic acid on serum metabolome in subjects with chronic inflammation
por: Chang, Wan-Chi, et al.
Publicado: (2021)

Common and differential effects of docosahexaenoic acid and eicosapentaenoic acid on helper T-cell responses and associated pathways
por: Lee, Jaeho, et al.
Publicado: (2021)

Formulation, Characterization and Optimization of Liposomes Containing Eicosapentaenoic and Docosahexaenoic Acids; A Methodology Approach
por: Hadian, Zahra, et al.
Publicado: (2014)

Age Stratification and Impact of Eicosapentaenoic Acid and Docosahexaenoic Acid to Arachidonic Acid Ratios in Ischemic Stroke Patients
por: Ueno, Yuji, et al.
Publicado: (2018)

Health benefits of docosahexaenoic acid and its bioavailability: A review
por: Li, Jia, et al.
Publicado: (2021)

Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review
por: Oscarsson, Jan, et al.
Publicado: (2017)

Fatty Acid Taste Receptor GPR120 Activation by Arachidonic Acid, Eicosapentaenoic Acid, and Docosahexaenoic Acid in Chickens
por: Kawabata, Fuminori, et al.
Publicado: (2022)

Plasma Docosahexaenoic Acid and Eicosapentaenoic Acid Concentrations Are Positively Associated with Brown Adipose Tissue Activity in Humans
por: Xiang, Angie S., et al.
Publicado: (2020)

Meta-Analysis of Contemporary Trials of Omega-3 Fatty Acids Containing Both Eicosapentaenoic and Docosahexaenoic Acids
por: Khan, Safi U., et al.
Publicado: (2021)

Erratum to: Common and differential effects of docosahexaenoic acid and eicosapentaenoic acid on helper T-cell responses and associated pathways
por: Lee, Jaeho, et al.
Publicado: (2021)

Comparative Effects of Mineral Oil, Corn Oil, Eicosapentaenoic Acid, and Docosahexaenoic Acid in an In Vitro Atherosclerosis Model
por: Sherratt, Samuel C. R., et al.
Publicado: (2023)

Dietary intake of eicosapentaenoic and docosahexaenoic acids is linked to gray matter volume and cognitive function in elderly
por: Titova, Olga E., et al.
Publicado: (2012)

Eicosapentaenoic and docosahexaenoic acid-enriched high fat diet delays the development of fatty liver in mice
por: Soni, Nikul K, et al.
Publicado: (2015)

Eicosapentaenoic and Docosahexaenoic Acid-Enriched High Fat Diet Delays Skeletal Muscle Degradation in Mice
por: Soni, Nikul K., et al.
Publicado: (2016)

Lipid Structure Influences the Digestion and Oxidation Behavior of Docosahexaenoic and Eicosapentaenoic Acids in the Simulated Digestion System
por: Beltrame, Gabriele, et al.
Publicado: (2023)

Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells
por: Siddiqui, Rafat A, et al.
Publicado: (2005)

Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome
por: Yagi, Shusuke, et al.
Publicado: (2015)

Chronic Arachidonic Acid Administration Decreases Docosahexaenoic Acid- and Eicosapentaenoic Acid-Derived Metabolites in Kidneys of Aged Rats
por: Katakura, Masanori, et al.
Publicado: (2015)

Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events
por: Le, Viet T., et al.
Publicado: (2023)

Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Prostate Cancer Cell Migration and Invasion Induced by Tumor-Associated Macrophages
por: Li, Cheng-Chung, et al.
Publicado: (2014)

Eicosapentaenoic acid/docosahexaenoic acid 1:1 ratio improves histological alterations in obese rats with metabolic syndrome
por: Taltavull, Núria, et al.
Publicado: (2014)

Effect of Eicosapentaenoic Acid and Docosahexaenoic Acid on Myogenesis and Mitochondrial Biosynthesis during Murine Skeletal Muscle Cell Differentiation
por: Hsueh, Tun-Yun, et al.
Publicado: (2018)

Effects of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Fetal Pulmonary Circulation: An Experimental Study in Fetal Lambs
por: Sharma, Dyuti, et al.
Publicado: (2017)

Effects of eicosapentaenoic acid and docosahexaenoic acid on C2C12 cell adipogenesis and inhibition of myotube formation
por: Ghnaimawi, Saeed, et al.
Publicado: (2019)

Erratum to: ‘Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome’
por: Yagi, Shusuke, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d3ilsg6l24h9d3p42h8orb8ffe